name: Nuclear Ab pattern.atypic speckled:Titr:Pt:Ser:SemiQn:IF


name: Nuclear Ab pattern.atypic speckled:PrThr:Pt:Ser:Ord:IF


name: Nuclear Ab pattern.nuclear matrix:Titr:Pt:Ser:SemiQn:IF


name: Nuclear Ab pattern.nuclear matrix:PrThr:Pt:Ser:Ord:IF


name: Nuclear Ab pattern.nuclear dots:PrThr:Pt:Ser:Ord:IF


name: Nuclear Ab pattern.nuclear dots:Titr:Pt:Ser:SemiQn:IF


name: Nuclear Ab pattern.multiple nuclear dots:PrThr:Pt:Ser:Ord:IF


name: Nuclear Ab pattern.multiple nuclear dots


name: Nuclear Ab pattern.multiple nuclear dots:Titr:Pt:Ser:SemiQn:IF


name: Centromere protein F Ab:PrThr:Pt:Ser:Ord:IF


name: Centromere protein F Ab:Titr:Pt:Ser:SemiQn:IF


name: Human upstream binding factor Ab:PrThr:Pt:Ser:Ord:IF


name: Human upstream binding factor Ab:Titr:Pt:Ser:SemiQn:IF


name: Nuclear Ab pattern.nuclear membrane pores:PrThr:Pt:Ser:Ord:IF


name: Nuclear Ab pattern.nuclear membrane pores


name: Nuclear Ab pattern.nuclear membrane pores:Titr:Pt:Ser:SemiQn:IF


name: Mutated citrullinated vimentin Ab:ACnc:Pt:Ser:Qn


name: U1 small nuclear ribonucleoprotein C Ab:PrThr:Pt:Ser:Ord


name: Nuclear pore protein gp210 Ab:PrThr:Pt:Ser:Ord


name: Deprecated Soluble liver Ab [Units/volume] in Serum


name: Deprecated Soluble liver Ab [Presence] in Serum


name: Smith extractable nuclear B Ab:PrThr:Pt:Ser:Ord


name: Smith extractable nuclear D Ab:PrThr:Pt:Ser:Ord


name: U1 small nuclear ribonucleoprotein A Ab:PrThr:Pt:Ser:Ord


name: Rickettsia spotted fever group Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Anaplasma phagocytophilum Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Ehrlichia chaffeensis Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Western equine encephalitis virus RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: HEDIS 2009-2013 Codes to identify cervical cancer screening tests (CCS-A):-:Pt:^Patient:-


name: HEDIS 2009-2011 Codes to identify HbA1c tests (CDC-D):-:Pt:^Patient:-


name: HEDIS 2009 Codes to identify LDLc screening (CDC-H):-:Pt:^Patient:-


name: HEDIS 2009 Codes to identify LDLc screening (CDC-H)


name: HEDIS 2009 Codes to identify nephropathy screening tests (CDC-J):-:Pt:^Patient:-


name: HEDIS 2009 Codes to identify nephropathy screening tests (CDC-J)


name: HEDIS 2009 Codes to identify evidence of nephropathy (CDC-K):-:Pt:^Patient:-


name: HEDIS 2009 Codes to identify evidence of nephropathy (CDC-K)


name: HEDIS 2009 Codes to identify sexually active women (CHL-B):-:Pt:^Patient:-


name: HEDIS 2009 Codes to identify sexually active women (CHL-B)


name: HEDIS 2009 Codes to identify Chlamydia screening (CHL-C):-:Pt:^Patient:-


name: HEDIS 2009 Codes to identify Chlamydia screening (CHL-C)


name: HEDIS 2009, 2010 Codes to identify exclusions (CHL-D):-:Pt:^Patient:-


name: HEDIS 2009 Codes to identify LDLc screening (CMC-D):-:Pt:^Patient:-


name: HEDIS 2009 Codes to identify LDLc screening (CMC-D)


name: HEDIS 2009 Codes to identify colorectal cancer screening (COL-A):-:Pt:^Patient:-


name: HEDIS 2009 Codes to identify colorectal cancer screening (COL-A)


name: HEDIS 2009 Codes to identify group A Streptococcus tests (CWP-D):-:Pt:^Patient:-


name: HEDIS 2009-2013 Codes to identify lead (LSC-A):-:Pt:^Patient:-


name: HEDIS 2009 Codes to identify physiologic monitoring tests (MPM-A):-:Pt:^Patient:-


name: HEDIS 2009 Codes to identify physiologic monitoring tests (MPM-A)


name: HEDIS 2009 Codes to identify physiologic monitoring tests - Blood urea nitrogen (BUN) (MPM-A):-:Pt:^Patient:-


name: HEDIS 2009 Codes to identify physiologic monitoring tests - Blood urea nitrogen (BUN) (MPM-A)


name: HEDIS 2009 Codes to identify physiologic monitoring tests - Serum creatinine (SCr) (MPM-A):-:Pt:^Patient:-


name: HEDIS 2009 Codes to identify physiologic monitoring tests - Serum creatinine (SCr) (MPM-A)


name: HEDIS 2009 Codes to identify physiologic monitoring tests - Serum potassium (MPM-A):-:Pt:^Patient:-


name: HEDIS 2009 Codes to identify physiologic monitoring tests - Serum potassium (MPM-A)


name: HEDIS 2009 Codes to identify anticonvulsant serum concentration monitoring tests (MPM-E):-:Pt:^Patient:-


name: HEDIS 2009 Codes to identify anticonvulsant serum concentration monitoring tests (MPM-E)


name: HEDIS 2009 Codes to identify anticonvulsant serum concentration monitoring tests - carBAMazepine (MPM-E):-:Pt:^Patient:-


name: HEDIS 2009 Codes to identify anticonvulsant serum concentration monitoring tests - Carbamazepine (MPM-E)


name: HEDIS 2009-2011 Codes to identify anticonvulsant serum concentration monitoring tests - PHENobarbital (MPM-E):-:Pt:^Patient:-


name: HEDIS 2009, 2010 Codes to identify anticonvulsant serum concentration monitoring tests - Phenytoin (MPM-E):-:Pt:^Patient:-


name: HEDIS 2009-2013 Codes to identify anticonvulsant serum concentration monitoring tests - Valproate (MPM-E):-:Pt:^Patient:-


name: HEDIS 2009 Tests used in early prenatal care (PPC-C):-:Pt:^Patient:-


name: HEDIS 2009 Tests used in early prenatal care (PPC-C)


name: HEDIS 2009 Tests used in early prenatal care - ABO & Rh (PPC-C):-:Pt:^Patient:-


name: HEDIS 2009 Tests used in early prenatal care - ABO & Rh (PPC-C)


name: HEDIS 2009-2011 Tests used in early prenatal care - Cytomegalovirus (PPC-C):-:Pt:^Patient:-


name: HEDIS 2009, 2010 Tests used in early prenatal care - Herpes simplex (PPC-C):-:Pt:^Patient:-


name: HEDIS 2009 Tests used in early prenatal care - Rubella (PPC-C):-:Pt:^Patient:-


name: HEDIS 2009 Tests used in early prenatal care - Rubella (PPC-C)


name: HEDIS 2009 Tests used in early prenatal care - Toxoplasma (PPC-C):-:Pt:^Patient:-


name: HEDIS 2009 Tests used in early prenatal care - Toxoplasma (PPC-C)


name: HEDIS 2009-2013 Codes to identify postpartum visits (PPC-E):-:Pt:^Patient:-


name: Post acute care or personal assistance anticipated following discharge:Find:Pt:^Patient:Ord:CARE


name: Post acute care or personal assistance anticipated following discharge


name: Clostridioides difficile toxin genes:PrThr:Pt:Stool:Ord:Probe.amp.tar


name: Endocrine newborn screening panel (SI units):-:Pt:Bld.dot:-


name: Endocrine newborn screening panel:-:Pt:Bld.dot:-


name: Thyroid newborn screening panel (SI units):-:Pt:Bld.dot:-


name: Cystic fibrosis newborn screening panel:-:Pt:^Patient:-


name: Galactosemia newborn screening panel:-:Pt:Bld.dot:-


name: Galactosemia newborn screening panel (SI units):-:Pt:Bld.dot:-


name: Hemoglobinopathies newborn screening panel:-:Pt:Bld.dot:-


name: Hemoglobinopathies newborn screening panel


name: Infectious diseases newborn screening panel:-:Pt:Bld.dot:-


name: Infectious diseases newborn screening panel


name: CFTR gene targeted mutation analysis:Prid:Pt:Bld.dot:Nom:Molgen


name: Thyroid newborn screening panel:-:Pt:Bld.dot:-


name: Identity testing:Prid:Pt:Index case^Comparison case:Nar:Molgen


name: Organophosphonate nerve agent metabolite panel:MCnc:Pt:Urine:-


name: Organophosphonate nerve agent metabolite panel


name: Newborn hearing screen method:Type:Pt:Ear:Nom


name: Newborn hearing screening panel:-:Pt:^Patient:-


name: Cause of death:Find:Pt:^Family member:Nom:USSG-FHT


name: Age range at death:Type:Pt:^Family member:Nom:USSG-FHT


name: Family member health history:-:Pt:^Family member:-:USSG-FHT


name: Age range at onset of disease:Type:Pt:^Family member:Nom:USSG-FHT


name: History of diseases:Hx:Pt:^Family member:Nom:USSG-FHT


name: Diseases history panel:-:Pt:^Family member:-:USSG-FHT


name: US Surgeon General family health portrait:-:Pt:^Patient:-:USSG-FHT


name: US Surgeon General family health portrait


name: Age range at onset of disease:Type:Pt:^Patient:Nom:USSG-FHT


name: ACTH stimulation test using IM corticosteroids


name: ACTH stimulation test using IV corticosteroids


name: United States Surgeon General Family Health Tool (USSGFHT) survey


name: United States Surgeon General Family Health Tool (USSGFHT) set


name: Healthcare Effectiveness Data and Information Set panel


name: uncorrected for compressible gas volume setting


name: 1.5 hour post dose ornithine alpha-ketoglutarate


name: 15 minutes post dose ornithine alpha-ketoglutarate


name: 15 minutes pre dose ornithine alpha-ketoglutarate


name: 1 hour post dose ornithine alpha-ketoglutarate


name: 2.5 hour post dose ornithine alpha-ketoglutarate


name: 2 hour post dose ornithine alpha-ketoglutarate


name: 30 minutes post dose ornithine alpha-ketoglutarate


name: 3 hours post dose ornithine alpha-ketoglutarate


name: 45 minutes post dose ornithine alpha-ketoglutarate


name: during aorta stenosis maximum velocity measurement


name: during mitral regurgitation maximum velocity measurement


name: during right ventricular septal defect maximum velocity measurement


name: on ventilator.volume targeted assist and control


name: Acute hospital admission considered appropriate


name: Altered level of consciousness/alertness during 2 day assessment period


name: Bacterial vaginosis & vaginitis DNA panel


name: Brief interview for mental status was attempted


name: Continuity assessment record and evaluation tool - Post acute care - admission


name: Continuity assessment record and evaluation tool - Post acute care - discharge


name: Continuity assessment record and evaluation tool - master document - core and supplemental items


name: Carnitine.free (C0)+Acetylcarnitine (C2)+Propionylcarnitine (C3)+Palmitoylcarnitine (C16)+Oleoylcarnitine (C18:1)+Stearoylcarnitine (C18)


name: Cell count & Differential panel with Glucose & Protein


name: Direct antiglobulin test.complement C3 specific reagent


name: Direct antiglobulin test.complement C3+C4 specific reagent


name: Discharge destination influenced by caregiver availability


name: Discharged with referral for additional services


name: Disorganized thinking during 2D assessment period


name: Follow-up (referred to) provider &or specialist, catchment location indicator


name: Follow-up (referred to) provider &or specialist, state location indicator


name: Mycobacterium tuberculosis tuberculin stimulated gamma interferon/Mitogen stimulated gamma interferon


name: Inattention during 2 day assessment period


name: Inpatient rehabilitation hospital considered appropriate


name: Intravascular systolic.brachial artery right


name: Intravascular systolic.posterior tibial artery left


name: Intravascular systolic.posterior tibial artery right


name: Known allergies or adverse drug reactions


name: Lactate dehydrogenase in pericardial fluid


name: Leukocyte-poor plateletpheresis units given


name: Long term care hospital considered appropriate


name: Long term care nursing facility considered appropriate


name: Long-term personal care services considered appropriate


name: Major treatments admitted &or discharged with


name: Major treatments admitted &or discharged with panel


name: Management of equipment assistance needed


name: Medical procedures &or treatments assistance needed


name: Medical services received in the last 2Mo


name: Medication administration assistance needed


name: Memory &or recall ability during 2D assessment period


name: Mobility devices and aids used prior to current illness, exacerbation, or injury


name: Observational Assessment of Cognitive Status at 2D Assessment Period


name: Other disruptive or dangerous behavioral symptoms not directed towards others, including self-injurious behaviors during 2D assessment period


name: Outpatient services considered appropriate


name: Pain Effect on Function during last 2 days


name: Patient History Prior to this Current Illness, Exacerbation, or Injury


name: Patient Identification Number or Provider Account Number


name: Patient lived with prior to this illness


name: Patient requested information not be shared with next provider


name: Physical behavioral symptoms directed toward others during 2D assessment period


name: Primary diagnosis code from previous setting


name: Psychiatric hospital considered appropriate


name: Psychomotor retardation during 2D assessment period


name: Reason brief interview for mental status was not attempted


name: Reason for discharge delay.other specified


name: Skilled nursing facility considered appropriate


name: Structural barriers in prior residence that could interfere with the patient's discharge


name: Supervision and safety assistance needed


name: Temporal orientation - current day of the week


name: Transfuse 5% plasma protein fraction units


name: Transfuse frozen erythrocytes newborn units


name: Transfuse leukocyte-poor plateletpheresis units


name: Transfuse leukocyte-poor platelets units


name: Transfuse pooled fresh frozen plasma units


name: Unable to assess memory &or recall ability during 2D assessment period .specified reason


name: Urea nitrogen peritoneal dialysis clearance


name: Verbal behavioral symptoms directed towards others during 2D assessment period


name: Volume at 25-75% of forced expiration.measured.post bronchodilation


name: Volume at 25-75% of forced expiration.measured.pre bronchodilation


name: American College of Medical Genetics and Genomics


name: Clinical.estimated from prior assessment


name: Immunofluorescence (IF) rat liver+stomach+kidney substrate


name: NAACCR Asian and Pacific Islander Identification Algorithm (NAPIIA)


name: Velocity-time integral.XXX/Velocity-time integral 2.XXX


name: Incision of bone of carpals and metacarpals, NOS


name: Deprecated Activated partial thrombplastin time (aPTT) in Blood from control by Coagulation assay


name: PABPN1 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: HFE gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Shuangling Fuzheng anticancer preparation


name: Vincristine-Dactinomycin-Doxorubicin Wilm's Tumor Regimen


name: Phenytoin.total/Phenytoin.free [Mass ratio] in Serum or Plasma


name: FMR1 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Ferritin [Mass or Moles/volume] in Serum or Plasma


name: GBA gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: GJB2 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: GLA gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Insulin^pre or post dose glucose:SCnc:Pt:Ser/Plas:Qn


name: Deprecated Streptococcus pneumoniae 26 Ab [Units/volume] in Serum --2nd specimen


name: Deprecated Streptococcus pneumoniae 51 Ab [Units/volume] in Serum --2nd specimen


name: Deprecated Streptococcus pneumoniae 56 Ab [Units/volume] in Serum --1st specimen


name: Deprecated Streptococcus pneumoniae 56 Ab [Units/volume] in Serum --2nd specimen


name: Deprecated Streptococcus pneumoniae 9n Ab [Units/volume] in Serum --1st specimen


name: Deprecated Fungus identified in Blood by Culture


name: Deprecated Provider-unspecified progress note


name: MERRF gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Medication administered:Cmplx:Pt:Psychiatric rehabilitation treatment:Set


name: Latvian translation of the Medical Subject Headings


name: Administration of Wechsler Intelligence Scale for Children


name: Deprecated Kentucky blue grass IgE Ab [Units/volume] in Serum


name: Deprecated Oat pollen IgE Ab [Units/volume] in Serum


name: Deprecated CD16+CD57+ cells/100 cells in Blood


name: Deprecated Sagebrush IgE Ab [Units/volume] in Serum


name: Include all data of the selected type on or after the date of service:Scope.modifier.selection item:Pt:X12^277:-


name: Deprecated Monoacetylmorphine [Presence] in Urine


name: Views^W contrast transhepatic:Find:Pt:Abdomen>Portal vein:Doc:RF.angio


name: STEVENS-JOHNSON SYNDROME, SUSCEPTIBILITY TO


name: incision of right lower paraspinal region extending to bone (physical finding)


name: Lissamine Green Ophthalmic Test Strips 1.5mg


name: {21 (desogestrel 0.15 MG / ethinyl estradiol 0.02 MG Oral Tablet) / 5 (ethinyl estradiol 0.01 MG Oral Tablet) / 2 (inert ingredients 1 MG Oral Tablet) } Pack [Azurette 28 Day]


name: nutritional therapy, metabolic dis., mv, min no.2


name: Opti-Free Express Multi-Purpose Solution


name: doxycycline monohydrate/salicylic acid/octinoxate/zinc oxide 100 mg-2 %-SPF 30 MISCELL KIT


name: Medical Food Oral Powder for Solution [Axona]


name: {5 (milnacipran hydrochloride 12.5 MG Oral Tablet) / 8 (milnacipran hydrochloride 25 MG Oral Tablet) / 42 (milnacipran hydrochloride 50 MG Oral Tablet) } Pack


name: {5 (milnacipran hydrochloride 12.5 MG Oral Tablet [Savella]) / 8 (milnacipran hydrochloride 25 MG Oral Tablet [Savella]) / 42 (milnacipran hydrochloride 50 MG Oral Tablet [Savella]) } Pack [Savella 4-Week Titration]


name: {1 (30 ML) (hydrocortisone 20 MG/ML Topical Lotion) / 1 (118 ML) (salicylic acid 20 MG/ML / sulfur 20 MG/ML Medicated Shampoo) } Pack


name: {1 (30 ML) (hydrocortisone 20 MG/ML Topical Lotion [Scalacort]) / 1 (118 ML) (salicylic acid 20 MG/ML / sulfur 20 MG/ML Medicated Shampoo) } Pack [Scalacort DK]


name: BANDAGE TUBULAR ELASTIC 3IN X 11YD GLD10


name: BANDAGE TUBULAR ELASTIC 4IN X 11YD GLF10


name: CATHERIZATION SET,INTERMITTENT 10FR C#28006


name: CATHERIZATION SET,INTERMITTENT 12FR BARD #4A3052


name: CATHERIZATION SET,INTERMITTENT 12FR BARD #4A3054-FEMALE


name: CATHERIZATION SET,INTERMITTENT 12FR C#28003-FEMALE


name: CATHERIZATION SET,INTERMITTENT 12FR C#28007


name: CATHERIZATION SET,INTERMITTENT 14FR BARD #4A3053


name: CATHERIZATION SET,INTERMITTENT 14FR BARD #4A3055-FEMALE


name: CATHERIZATION SET,INTERMITTENT 14FR C#28004-FEMALE


name: CATHERIZATION SET,INTERMITTENT 14FR C#28008


name: CATHERIZATION SET,INTERMITTENT 14FR C#28032


name: CATHERIZATION SET,INTERMITTENT 14FR C#28034-FEMALE


name: CATHERIZATION SET,INTERMITTENT 16FR C#28009


name: CATHERIZATION SET,INTERMITTENT 16FR C#28033


name: CATHERIZATION SET,INTERMITTENT 8FR C#28005


name: CATHETER,INTERMITTENT,CLOSED SYSTEM 16FR RUSCH #MMG-ONC-16


name: DRESSING,BIOSTEP AG 2IN X 2IN U#66800126


name: DRESSING,BIOSTEP AG 4IN X 4IN U#66800122


name: DRESSING,MAXORB EXTRA AG 4 X 4.75IN #MSC9445


name: FEEDING BAG W/PUMP SET KENDALL #8884773642


name: FISTULA AND WOUND MANAGEMENT SYSTEM COLOPLAST #14050


name: FISTULA AND WOUND MANAGEMENT SYSTEM COLOPLAST #14060


name: FISTULA AND WOUND MANAGEMENT SYSTEM COLOPLAST #14070


name: PROTEIN SUPPLEMENT,PROTEINEX 15 LIQUID,ORAL


name: SALIVA,ARTIFICIAL (BIOTENE MOUTH) SPRAY,ORAL


name: TRACH TUBE,SZ 5 SINGLE CANNULA SHLY 5SCT


name: TRACH TUBE,SZ 6 SINGLE CANNULA SHLY 6SCT


name: TRACH TUBE,SZ 7 SINGLE CANNULA SHLY 7SCT


name: TRACH TUBE,SZ 8 SINGLE CANNULA SHLY 8SCT


name: TRACH TUBE,SZ 9 SINGLE CANNULA SHLY 9SCT


name: TUBING,AIRLIFE CORRUGATED FLEX POLYETHYLENE AND EVA


name: UNDERGARMENT,SURGILAST LG/XLG MESH PANTS


name: UNDERGARMENT,SURGILAST SM/MED MESH PANTS


name: {10 (lamotrigine 25 MG Oral Tablet) } Pack


name: Anti-citrullinated protein antibody detected


name: Anti-cyclic citrullinated peptide antibody negative


name: Effective peritoneal surface area increased


name: Drainage of cerebrospinal fluid (procedure)


name: Von Willebrand's factor antigen decreased


name: Von Willebrand's factor activity abnormal


name: Von Willebrand's factor activity increased


name: Von Willebrand's factor antigen abnormal


name: Musculoskeletal and connective tissue pain and discomfort


name: Product contamination and sterility issues


name: Peripherally inserted central catheterisation


name: Product contamination particulate matter


name: Prostatic greenlight laser vapourisation


name: Large granular lymphocyte count increased


name: Unit-dose blister packaging partial fill


name: Wrong product and correct product in same container


name: Wrong and correct product strengths in same container


name: Product measured potency decrease over time


name: Product substitution issue brand to generic


name: Product substitution issue brand to brand


name: Product substitution issue generic to generic


name: Arrhythmia related investigations, signs and symptoms (SMQ)


name: Central nervous system haemorrhages and cerebrovascular conditions (SMQ)


name: Cardiac arrhythmia terms, nonspecific (SMQ)


name: Bradyarrhythmia terms, nonspecific (SMQ)


name: Tachyarrhythmia terms, nonspecific (SMQ)


name: Central nervous system vascular disorders, not specified as haemorrhagic or ischaemic (SMQ)


name: Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (SMQ)


name: Depression (excl suicide and self injury) (SMQ)


name: Premalignant disorders, general conditions and other site specific disorders (SMQ)


name: Skin neoplasms, malignant and unspecified (SMQ)


name: {25 (prednisone 10 MG Oral Tablet) } Pack


name: Estradiol Hemihydrate, hemihydrate compounding powder


name: estradiol hemihydrate compounding powder


name: Progesterone Micronized, compounding powder


name: POUCH,DRAINABLE,PREMIER HIGH OUTPUT H#80110


name: {7 (desogestrel 0.1 MG / ethinyl estradiol 0.025 MG Oral Tablet) / 7 (desogestrel 0.125 MG / ethinyl estradiol 0.025 MG Oral Tablet) / 7 (desogestrel 0.15 MG / ethinyl estradiol 0.025 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Caziant 28 Day]


name: codeine / diphenhydramine / phenylephrine


name: {14 (24 HR clarithromycin 500 MG Extended Release Oral Tablet) } Pack


name: {150 (doxycycline monohydrate 100 MG Oral Tablet [Avidoxy]) / 1 (118 ML) (salicylic acid 20 MG/ML Medicated Liquid Soap) } Pack [Avidoxy Pack]


name: Quality Choice 31G 5/16 inch Pen Needle (Short)


name: {30 (doxycycline monohydrate 150 MG Oral Tablet) } Pack


name: pen needle, diabetic, safety 29 gauge X 5/16" MISCELL NEEDLE, DISPOSABLE


name: nut.therapy, phenylketonuria(PKU) with iron, no.37


name: nutritional therapy for impaired digestive function ORAL PACKET (EA)


name: phosphatidylcholine 100 % MISCELL POWDER (GRAM)


name: skin cleanser combination no.15 TOPICAL CLEANSER (ML)


name: diluent for insulin aspart and detemir no.1


name: emollient combination no.39 TOPICAL CREAM (GRAM)


name: emollient combination no.39 TOPICAL LIQUID (ML)


name: emollient combination no.40 TOPICAL LOTION (GRAM)


name: emollient combination no.41 TOPICAL LIQUID (GRAM)


name: Ascorbic Acid/Calcium/Copper/Cyanocobalamin/Folic Acid/Iron/Magnesium/Niacinamide/Pyridoxine/Riboflavin/Thiamine/Vitamin A/Vitamin D/Vitamin E/Zinc;Docosahexaenoic Acid/Omega-3 Fatty Acids 120 MG-200 MG-2 MG-0.012 MG-1 MG-29 MG-25 MG-20 MG-25 MG-4 MG-1.8 MG-3000 IU-400 IU-30 MG-25 MG; 200 MG-250 MG Oral Kit [Trust Natal DHA]


name: regulation of cilium beat frequency involved in ciliary motility


name: regulation of ryanodine-sensitive calcium-release channel activity


name: negative regulation of ryanodine-sensitive calcium-release channel activity


name: positive regulation of ryanodine-sensitive calcium-release channel activity


name: negative regulation of response to type II interferon


name: positive regulation of response to type II interferon


name: type II interferon-mediated signaling pathway


name: type I interferon-mediated signaling pathway


name: regulation of Fc receptor mediated stimulatory signaling pathway


name: positive regulation of Fc receptor mediated stimulatory signaling pathway


name: growth hormone receptor signaling pathway via JAK-STAT


name: positive regulation of gastric acid secretion


name: negative regulation of gastric acid secretion


name: positive regulation of digestive system process


name: negative regulation of digestive system process


name: intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress


name: ciliary neurotrophic factor-mediated signaling pathway


name: regulation of biomineral tissue development


name: positive regulation of biomineral tissue development


name: negative regulation of tooth mineralization


name: positive regulation of tooth mineralization


name: negative regulation of enamel mineralization


name: positive regulation of enamel mineralization


name: regulation of nucleotide-binding oligomerization domain containing signaling pathway


name: negative regulation of nucleotide-binding oligomerization domain containing signaling pathway


name: nucleotide-binding oligomerization domain containing 1 signaling pathway


name: nucleotide-binding oligomerization domain containing 2 signaling pathway


name: thrombin-activated receptor signaling pathway


name: positive regulation of germ tube formation


name: negative regulation of germ tube formation


name: regulation of appressorium formation on or near host


name: positive regulation of appressorium formation on or near host


name: modulation of formation of symbiont germ tube hook structure for appressorium development


name: positive regulation of formation of symbiont germ tube hook structure for appressorium development


name: negative regulation of formation of symbiont germ tube hook structure for appressorium development


name: regulation of formation by symbiont of haustorium for nutrient acquisition from host


name: positive regulation of formation by symbiont of haustorium for nutrient acquisition from host


name: negative regulation of formation by symbiont of haustorium for nutrient acquisition from host


name: modulation of symbiont penetration peg formation for entry into host


name: positive regulation of symbiont penetration peg formation for entry into host


name: regulation of infection cushion formation


name: positive regulation of infection cushion formation


name: negative regulation of infection cushion formation


name: positive regulation of hyphopodium formation


name: negative regulation of hyphopodium formation


name: regulation of haustorium mother cell formation


name: positive regulation of haustorium mother cell formation


name: negative regulation of haustorium mother cell formation


name: modulation of symbiont haustorium neck formation for entry into host


name: positive regulation of symbiont haustorium neck formation for entry into host


name: regulation of penetration hypha formation


name: positive regulation of penetration hypha formation


name: positive regulation of spore encystment on host


name: negative regulation of spore encystment on host


name: modulation of zoospore encystment on host


name: positive regulation of zoospore encystment on host


name: negative regulation of zoospore encystment on host


name: modulation of sporangium germination on or near host


name: positive regulation of sporangium germination on or near host


name: negative regulation of sporangium germination on or near host


name: positive regulation of encysted zoospore germination


name: negative regulation of encysted zoospore germination


name: positive regulation of oogonium development


name: negative regulation of oogonium development


name: positive regulation of aecium development


name: negative regulation of aecium development


name: regulation of zygosporangium development


name: positive regulation of zygosporangium development


name: negative regulation of zygosporangium development


name: positive regulation of telium development


name: negative regulation of telium development


name: positive regulation of uredinium development


name: negative regulation of uredinium development


name: positive regulation of conidium formation


name: negative regulation of conidium formation


name: positive regulation of sporangium development


name: negative regulation of sporangium development


name: positive regulation of basidium development


name: negative regulation of basidium development


name: regulation of oomycete sporangium development


name: positive regulation of oomycete sporangium development


name: negative regulation of oomycete sporangium development


name: regulation of arbuscule formation for nutrient acquisition from host


name: positive regulation of arbuscule formation for nutrient acquisition from host


name: negative regulation of arbuscule formation for nutrient acquisition from host


name: regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion


name: regulation of cardiac muscle contraction by calcium ion signaling


name: regulation of macrophage tolerance induction


name: regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion


name: positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion


name: negative regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion


name: maintenance of secretory granule location


name: maintenance of dense core granule location


name: maintenance of protein localization in cell


name: regulation of symbiosis, encompassing mutualism through parasitism


name: regulation of respiratory system process


name: Skin-Hair-Eye Pigmentation, Variation In, 9


name: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 7


name: ADENOMATOUS POLYPOSIS COLI WITH CONGENITAL CHOLESTEATOMA


name: Neurologic regression following seizure onset


name: EEG shows slowed dysrhythmia and multifocal discharges


name: Skin-Hair-Eye Pigmentation, Variation In, 8


name: Neurologic regression around age 3 months


name: Decreased activity of galactocerebrosidase


name: Ataxia (type I and type II, infantile and juvenile)


name: Mental retardation, moderate to severe (type II, infantile and juvenile)


name: Myoclonus (type I and type II, infantile and juvenile)


name: Hypotonia (type I and type II, infantile)


name: Short stature (type II, infantile and juvenile)


name: Cherry-red spot (type II, infantile and juvenile and type I)


name: Lens opacities (type II, infantile and juvenile)


name: Dysostosis multiplex (type II, all types)


name: Epiphyseal stippling (type II, congenital)


name: Periosteal cloaking (type II, congenital)


name: Neuraminidase deficiency (white blood cells, fibroblasts, cultured amniotic cells)


name: Lesions in basal ganglia, brainstem, cerebellum, thalamus, spinal cord characterized by demyelination, necrosis, gliosis, spongiosis, and capillary proliferation


name: Muscle biopsy shows degenerating endplates and junctional folds


name: Electromyographic decrements in some muscles


name: Decreased endplate potential and amplitudes


name: Upper limb involvement occurs later or not at all


name: Increased connective tissue and fat in muscles


name: Congenital cardiac malformations have been rarely reported in severe cases


name: Decreased fibroblast iduronate sulfatase


name: Decreased N-acetylglucosamine-1-phosphotransferase (GlcNAc - phosphotransferase) using lysosomal enzymes


name: Normal-to-slightly decreased GlcNAc phosphotransferase using artificial substrate (e.g., alpha-methylmannoside)


name: Liver tissue shows 80 to 99% depletion of mitochondrial DNA (mtDNA) with decreased activities of mitochondrial-encoded respiratory chain complexes


name: 'Swedish key' proximal femur (flat proximal femoral metaphysis with medial spike and exaggerated lesser tuberosity)


name: Accessory ossification proximal phalanx, 2nd digit


name: Increased urinary hydroxyisovaleric acid


name: Decreased activity of 3-methylglutaconyl-CoA hydratase


name: Normal or mildly decreased arylsulfatase A activity


name: Submucosal macrophages filled with sphingolipids


name: Incomplete distal renal tubular acidosis


name: Intrahepatic cholestasis, episodic, recurrent


name: Increased susceptibility to schizophrenia


name: Neurobehavioral changes associated with hyperammonemia


name: Mental impairment may develop with repeated acute episodes


name: Decreased or absent serum and urinary chenodeoxycholic acid and cholic acid


name: Displaced nipples due to chest asymmetry


name: Asymmetric growth involving 1 or more body parts, isolated


name: Granulomas can appear on skin, tongue, lungs, or other tissues


name: Cataracts, formation may be reversible with early dietary management


name: Bleeding episodes (epistaxis, menorrhagia, ecchymosis)


name: Skin-Hair-Eye Pigmentation, Variation In, 5


name: Decreased number or absence of anchoring fibrils at dermal-epidermal junction


name: Multiple tissue biopsies show lysosomal storage disease


name: Decreased activity of glycosylceramidase, galactosylceramidase, ceramidase, and other lysosomal enzymes


name: Skeletal muscle shows decreased activities of mitochondrial respiratory complexes I, III, IV, and V


name: Generalized epiphyseal ossification delay


name: Minicore-like lesions with mitochondrial depletion and sarcomeric disorganization


name: Dense, irregular pelvic rim ('lacy' appearance)


name: Spasmodic dysphonia due to laryngeal spasm


name: Coma may occur after force feeding of high protein diet


name: Psychotic episodes have been rarely reported


name: Impaired renal absorption of cationic amino acids


name: Impaired intestinal absorption of cationic amino acids


name: Urinary excretion of cationic amino acids (lysine, arginine, ornithine)


name: Decreased blood levels of cationic amino acids


name: Defective antigen-specific skin response


name: Decreased transferrin Increased serum iron


name: Increased serum and urinary 2-oxoglutarate


name: Small or absent nails on the hands and feet


name: Tubular defect in presecretory reabsorption of urate


name: Exercise-induced acute renal failure with acute tubular necrosis


name: Specific visual spatial processing defect


name: Increased vascularization, reduced collagen bundle size


name: Pseudomembranous inflammation of the vaginal mucosa or cervix


name: Pseudomembranous, calcified plaques in the renal collecting system


name: Pseudomembranous inflammation of the gastrointestinal mucosa


name: Pseudomembranous inflammation of the middle ear


name: Formation of mucosal pseudomembranes that progress to plaques


name: Pseudomembranous inflammation of the oral mucosa


name: Subepithelial fibrin deposition with inflammation (pseudomembranous inflammation) of mucosal tissues


name: Pseudomembranous inflammation of the sinuses


name: Pseudomembranous inflammation of the nasopharynx


name: Pseudomembranous inflammation of the larynx


name: Pseudomembranous inflammation of the bronchi


name: Pseudomembranous inflammation of the lung


name: No increased risk of thrombotic vascular events


name: Increased levels of 3-alpha-7-alpha-12-alpha-trihydroxy-5-beta-cholestanoic acid (THCA) in bile, urine, and serum


name: Infiltration of lamina propria with plasma cells and lymphocytes


name: IigA and IgG antigliadin antibodies (AGA)


name: Anti-tissue transglutaminase antibodies (anti-tTG)


name: Stereotypic behaviors (hand-washing movements, head-banging)


name: Skin-Hair-Eye Pigmentation, Variation In, 6


name: Lung hypoplasia (secondary to oligohydramnios)


name: Herniation and elongation of the cerebellar tonsils, cerebellar vermis, brainstem, and fourth ventricle through the foramen magnum


name: Open spina bifida (myelomeningocele, 182940)


name: Raised, yellowish-gray gelatinous masses (subepithelium and anterior stroma)


name: Narrowing of the ureteropelvic junctions


name: High refractive errors (hyperopia, myopia, with-the-rule astigmatism)


name: Misrouting of the optic nerves at the chiasm


name: Absent stereopsis due to anomalous decussation at the optic chiasm


name: Positive angle kappa (appearance of exotropia but no shift on cover test)


name: Congenital quadruple amputation of upper and lower extremities


name: Complete amputation of distal humeral epiphyses


name: Bohomoletz bone (ectopic bone at distal end of humerus)


name: Skeletal muscle biopsy shows fiber size variability


name: Increased interstitial connective tissue


name: VON HIPPEL-LINDAU SYNDROME, MODIFIERS OF


name: Hearing loss, sensorineural, associated with ELSTs


name: Breakdown of the blood retinal barrier with retinal neovascularization


name: Peripheral retinal pigment epithelium atrophy


name: Retinal pigmentation anterior to boundary of the staphyloma in younger patients


name: Pigmentary retinopathy throughout the posterior pole and into the staphyloma in older individuals


name: Reduced axial length (nanophthalmos) if no staphyloma


name: Glaucoma, chronic angle-closure, in older patients


name: Reduced electroretinogram (scotopic > photopic) becoming extinguished in older patients


name: Sensorineural deafness, progressive, late-onset


name: Increased erythrocyte sedimentation rate, episodic


name: Skin/Hair/Eye Pigmentation, Variation In, 7


name: Maternal hypertension (after 20th week gestation, resolved postpartum)


name: Poor anticoagulant response to exogenous activated protein C as measured by the activated partial thromboplastin time (APTT)


name: Increased serum thrombopoietin may occur


name: Hyperreflexia, especially of the lower limbs


name: Loss of pain and temperature in a cape-like distribution


name: Touch, vibration, and limb position may or may not be affected


name: Segmental sensory loss, especially of pain and temperature


name: Associated with abnormalities at the foramen magnum, especially Chiari malformation type I (118420)


name: Impaired release of platelet adenosine diphosphate (ADP)


name: Myoclonic spasms, superimposed episodic, severe, painful (characterized by activation of antagonistic muscle pairs, may involve facial muscles)


name: Delayed tooth eruption, primary and secondary


name: Cerebrovascular ischemic attacks, transient (proceed secondary neurologic findings)


name: Associated with serum anti-phospholipid antibodies in about 50% of patients


name: Livedo racemosa (usually on trunk and/or lower extremities)


name: VITAMIN B12 PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1


name: Progressive reticulate hyperpigmentation (axillae, groin, perineal, perianal)


name: Filiform epithelial downgrowth of epidermal rete ridges


name: HLA antigens CW6, B13, B17 associated with psoriasis


name: Red, raised, scaly skin patches (elbows, knees, scalp)


name: Increased platelet aggregation with ristocetin


name: Decreased high molecular weight plasma factor VIII/ vWF multimers


name: Cerebral thrombosis (e.g. 612283.0014 protein C deficiency)


name: Normal skin (no palmoplantar keratoderma)


name: Hypoplastic distal phalanges (fingers II-V, mild phenotype)


name: Absent distal and middle phalanges (severe phenotype)


name: Proximal interphalangeal joint fusion (symphalangism)


name: Supravalvular pulmonary stenosis, minimal


name: Moderately deforming osteogenesis imperfecta


name: Irregular, meshlike matrix lamellae in the histology of the iliac crest


name: Calcified interosseous membrane (forearms)


name: Metaphyseal bands adjacent to growth plate (distal femora, proximal tibiae, distal radii)


name: Elevated serum alkaline phosphatase during hyperplastic callus formation


name: Increased urinary collagen type I N-telopeptide excretion (NTx) during hyperplastic callus formation


name: Agenesis or hypoplasia of the corpus callosum


name: Atrophy of the frontal and parietal cortex


name: Increased percentage of naive IgD+ IgM+ CD27- B cells


name: Decreased percentage of IgD+ IgM+ CD27+ memory B cells


name: Decreased percentage of IgD- IgM- CD27+ class-switched memory B cells


name: Low IgG in adolescence (2 of 4 affected individuals)


name: Decreased cytotoxic activity of CD8+ T cells


name: Low peripheral neutrophil counts (absolute neutrophil count less than 500/microliter)


name: Neutrophil maturation in bone marrow intact


name: Skin tags on the upper part of the auricle


name: Michel aplasia (complete absence of inner ear structures)


name: Developmental delay (apparent after the first year of life)


name: Cerebral white matter atrophy, progressive


name: Sural nerve biopsy shows decrease in myelinated fibers


name: Large number of small vacuoles near cytoplasmic membrane in fibroblasts and macrophages


name: Large vacuoles with either myelinic or granular osmiophilic bodies


name: Unintelligible speech, vocalizations, grunting


name: Complex motor behavior such as sleep walking


name: Rhizomelic shortening of the long bones, particularly the upper limbs


name: Sensorimotor peripheral neuropathy, mild


name: Syndactyly, bilateral (2nd and 3rd toes)


name: Liver biopsy shows red autofluorescence and needle-like cytoplasmic inclusion bodies


name: Hearing loss, initially conductive, later mixed conductive-sensorineural


name: Resorption of cervical region of the teeth


name: Abnormal modeling, onset before focal disease (humerus, radius, ulna, tibia)


name: Coarse 'fish net' bone trabeculae, onset before focal disease


name: Rounded areas of trabecular loss (juxta-articular, metaphyseal, diaphyseal, early stage)


name: Enlargement of affected area (intermediate stage)


name: Complete loss of trabecular pattern (late stage)


name: Episodes of weakness can last 1 day to several weeks and can occur 1-3 times per month


name: Ubiquitin-positive intranuclear neuronal inclusions


name: Heterotopic bone formation in subcutaneous fat


name: Heterotopic bone formation in dermis and subcutaneous fat


name: Growth retardation of affected limbs due to heterotopic bone formation


name: Histology shows degeneration of retinal ganglion cells


name: Wasting, especially temporal, neck, and facial muscles


name: Weakness of ankle and toe extensor (dorsiflexor) muscles


name: Atrophy of ankle and toe extensor (dorsiflexor) muscles


name: Myoclonus, axial (predominantly in upper limbs, occurs at rest and increases with activity or changes in posture)


name: Subcortical origin of the myoclonus based on neurophysiologic studies


name: Dystonia (may spontaneously remit in childhood or adolescence)


name: LEAN BODY MASS QUANTITATIVE TRAIT LOCUS 1


name: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 14


name: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 13


name: Decreased expression of glycosylphosphatidylinositol-linked proteins (e.g., CD59 107271 and CD24 600274) on hematopoietic cells


name: Night blindness followed by complete blindness


name: Bone corpuscle-like pigmentation in equatorial and peripheral areas


name: Proximal weakness of the lower extremities


name: Increased muscle tone in the lower limbs


name: Slow saccades (with longer disease duration)


name: Ophthalmoparesis (with longer disease duration)


name: Painful swellings of the long bones, acute, recurrent attacks


name: Mental retardation, mild-borderline, nonprogressive


name: Ventricular arrhythmia (PVC, nonsustained VT, sustained VT)


name: Psychomotor retardation, mild to moderate


name: Increased urinary N-acetylated amino acids


name: Superficial skin peeling (limited to dorsa of hands and feet)


name: Blistering at junction of stratum granulosum and stratum corneum


name: Parkinsonism has been described in 1 family


name: Delayed motor milestones due to muscle weakness


name: Cap structures, when present, contain disorganized myofibrils and thickened Z bands


name: Congenital joint contracture (elbow and knees)


name: Peripheral retinal telangiectasia, capillary closure, leakage, and microaneurysm formation


name: Facial muscle weakness and atrophy, progressive


name: Upper arm and pelvic muscle weakness and atrophy (later onset)


name: Abdominal wall muscle weakness (later onset)


name: Foot extensor muscle weakness (later onset)


name: Wheelchair dependency in 20% of patients by age 40


name: Abnormal changes in the organization of the sarcolemma and the subsarcolemmal membrane cytoskeleton


name: Intracranial developmental venous anomalies


name: SKIN/HAIR/EYE PIGMENTATION 2, BLOND HAIR/FAIR SKIN


name: Hypolobulated megakaryocytes in the bone marrow


name: HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 12


name: Skeletal muscle biopsy shows hypertrophy of type 1 and 2 muscle fibers


name: Subluxation or fusion of the cervical vertebrae


name: Corneal sensitivity impairment (hypesthesia)


name: BUDD-CHIARI SYNDROME, SUSCEPTIBILITY TO, SOMATIC


name: Nonspecific granular appearance of retinal pigment epithelium


name: CROHN DISEASE-ASSOCIATED GROWTH FAILURE, SUSCEPTIBILITY TO


name: Muscle atrophy, especially quadriceps and forearm muscles


name: Muscle biopsy shows inflammation with T cells


name: Muscle biopsy shows myodegenerative changes with beta-amyloid and phosphorylated tau deposits


name: Thickening of the soft tissue of the nose


name: Reduced resorption of primary tooth roots


name: Abscesses are 'cold,' lacking erythema, heat, and swelling


name: Myopia, high-grade (average refractive error -7.04 diopters)


name: Distal muscle atrophy due to neurologic disease


name: Normal serum phytanic and pristanic acid


name: URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 4


name: Hypoplastic or dysplastic toes (3rd, 4th, and 5th)


name: Abnormal EEG (abnormal slowing of background activity)


name: Decreased activity of long-chain 3-hydroxyacyl-CoA dehydrogenase, long-chain 3-oxoacyl-CoA thiolase, and long-chain 2-enoyl-CoA hydratase


name: Decreased rapid automatized naming (RAN) speed


name: Relatively higher cognitive abilities than classic autism


name: BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 7


name: Loss of independent ambulation within a few years


name: Increased iron deposition in the basal ganglia


name: Hearing loss, unilateral or bilateral, conductive , sensorineural, or mixed


name: PITUITARY ADENOMA, ACTH-SECRETING, SOMATIC


name: POLYOSTOTIC FIBROUS DYSPLASIA, SOMATIC, MOSAIC


name: Platelets have decreased number of alpha-granules, large vacuoles, normal number of dense bodies on electron microscopy


name: Endothelial cell death with hypertrophy and polymorphism of surviving cells


name: Dystrophy does not recur after penetrating keratoplasty


name: DERMATITIS, ATOPIC, 2, SUSCEPTIBILITY TO


name: Restrictive external ophthalmoplegia, bilateral


name: ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 4


name: COLORECTAL CANCER, SUSCEPTIBILITY TO, 11


name: COLORECTAL CANCER, SUSCEPTIBILITY TO, 10


name: MEAN PLATELET VOLUME/COUNT QUANTITATIVE TRAIT LOCUS 3


name: MEAN PLATELET VOLUME/COUNT QUANTITATIVE TRAIT LOCUS 2


name: MEAN PLATELET VOLUME/COUNT QUANTITATIVE TRAIT LOCUS 1


name: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12


name: LEUKEMIA, CHRONIC LYMPHOCYTIC, SUSCEPTIBILITY TO, 5


name: LEUKEMIA, CHRONIC LYMPHOCYTIC, SUSCEPTIBILITY TO, 4


name: LEUKEMIA, CHRONIC LYMPHOCYTIC, SUSCEPTIBILITY TO, 3


name: ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1


name: BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2


name: BREAST CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2


name: OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2


name: Progeroid facial appearance (onset childhood)


name: Sensorineural hearing loss (onset early childhood)


name: Dense longitudinal metaphyseal striations (distal femur, radius, and ulna)


name: Unossified vertebral bodies (below level of T12)


name: Nonspecific inflammation shown on biopsy


name: Malabsorption of fat and fat-soluble vitamins


name: Normal serum levels of gamma-GGT (231950)


name: Erythema, blisters, pustules (cyclical, explosive episodes)


name: BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 10


name: Ventricular arrhythmia (PVC, VT, and VF)


name: B-scan ultrasound shows echogenic, placoid calcified lesions at the level of the sclera and choroid


name: Optical coherence tomography shows normal retina and retinal pigment epithelium overlying the sclerochoroidal lesions


name: Cylindromas may show malignant transformation


name: Cylindromas, multiple (face, trunk and extremities)


name: Cylindromas usually occur on the scalp may coalesce into large 'turban tumors'


name: Mosaic-like masses of epithelial cells surrounded by thin layers of PAS-positive stroma


name: Decreased staining for collagen VII at the dermal-epidermal junction


name: Retention of COL7A1 within endoplasmic reticulum in epidermal keratinocytes


name: Anchoring fibrils revert to normal with clinical resolution of the disease


name: Enamel is lost from tooth soon after eruption leaving the crown composed only of dentin


name: Conductive hearing loss to due otitis media


name: EPIDERMOLYSIS BULLOSA PRURIGINOSA, AUTOSOMAL DOMINANT


name: Increased serum C-reactive protein, episodic


name: Pain (sharp, boring, drilling, piercing)


name: Episodic subtype, headaches occur in clusters


name: Chronic subtype, headaches occur without remission for 1 year


name: Herniation of the cerebellar tonsils through the foramen magnum 5 mm or greater


name: Decreased volume of the posterior cranial fossa with normal hindbrain volume


name: Floaters, flashing lights, visual field cuts


name: Decreased volume of posterior cranial fossa


name: Cores have abrupt borders within normal regions of the muscle fiber


name: Hypoplasia of corpus callosum and cerebellar vermis


name: Normal neurological development is possible


name: Normal urinary cyclic AMP response to PTH administration


name: BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 14


name: BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 13


name: Fibroblasts show lamellar lysosomal inclusions on electron microscopy


name: Cognitive defects in executive function and attention


name: Most patients do not achieve independent sitting or walking


name: Generalized cerebral, cerebellar, and brainstem atrophy, progressive


name: ALBINISM, OCULOCUTANEOUS, TYPE II, MODIFIER OF


name: CAROTENOIDS, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 1


name: Skin-Hair-Eye Pigmentation, Variation In, 4


name: WHITE BLOOD CELL COUNT QUANTITATIVE TRAIT LOCUS 1


name: Neurologic symptoms, if present, usually result from associated syringomyelia


name: Hypoplasia of cervical paravertebral muscles


name: Invagination of the foramen magnum upward into the posterior cranial fossa


name: Translocation of the upper cervical vertebrae into the cranial depression


name: Base of the skull is flattened on the cervical spine


name: INTRACRANIAL HEMORRHAGE IN BRAIN ARTERIOVENOUS MALFORMATIONS, SUSCEPTIBILITY TO


name: Ventricular arrhythmia (PVC, NSVT, and VT)


name: LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 5


name: Peripheral axonal neuropathy, distal, vasculitic


name: Sural nerve biopsy shows axonal degeneration


name: Impaired sensation of all modalities, distal


name: Episodic, nonpruritic, nonurticarial, nonpitting edema


name: Enamel has horizontal row of pits or linear depressions


name: Incisal edge or occlusal surface not usually involved


name: Patchy round or oval hair loss (alopecia areata)


name: Alopecia totalis (entire loss of scalp hair)


name: Alopecia universalis (entire loss of all hair on body)


name: Peribulbar lymphocytic infiltrate (on scalp biopsy)


name: Increased succinyladenosine (S-Ado) in serum, urine, and CSF


name: Increased succinylaminoimidazole carboxamide ribotide (SAICAr)


name: Galactorrhea from increased serum prolactin


name: Multiple, flat, skin-colored warty papules (2-4mm in diameter on dorsum hands, feet, knees, and elbows)


name: Increased risk of breast cancer in women


name: Symmetric osseous and/or cutaneous syndactyly of hands


name: Symmetric osseous and/or cutaneous syndactyly of feet


name: Hypomyelination of the brain white matter, diffuse


name: Delayed walking and running in early childhood


name: Abnormal urinary collagen-derived pyridinium crosslinks (absent Glc-Gal-PYD)


name: Decreased serum glucosyltransferase (GGT) activity


name: Hearing loss, bilateral sensorineural (profound)


name: Tenascin X deficiency (serum and fibroblasts)


name: Mental retardation, moderate-severe (2p21del)


name: Rapid weight gain in late childhood (HCS)


name: Failure to thrive (birth to 6-8 years) (HCS)


name: Decreased fetal movements (2p21del and HCS)


name: Transient neonatal hypocalcemia (2p21del)


name: Transient neonatal hypoglycemia (2p21del)


name: Increased urinary cystine, arginine, lysine, and ornithine (HCS and 2p21del)


name: Normal mitochondrial respiratory chain complex I-V (HCS)


name: Decreased mitochondrial respiratory chain complex (2p21del)


name: FASTING INSULIN LEVEL QUANTITATIVE TRAIT LOCUS 1


name: Hypotension, postural, due to autonomic dysfunction


name: PLASMA BETA-AMYLOID-42 LEVEL QUANTITATIVE TRAIT LOCUS


name: Intrahepatic cholestasis, episodic, recurrent, may be permanent in some patients later in life


name: Progression to end-stage liver disease does not occur


name: Normal or mildly increased serum gamma-GGT (231950)


name: Decreased CSF 3-methoxy-4-hydroxyphenylethyleneglycol (MHPG)


name: Decreased activity of tyrosine hydroxylase


name: FECH, ASN408LYS, PRO409SER, AND CYS411GLY


name: ALKALINE PHOSPHATASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 4


name: ALKALINE PHOSPHATASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 3


name: ALKALINE PHOSPHATASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 2


name: GAMMA GLUTAMYLTRANSFERASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 2


name: GAMMA GLUTAMYLTRANSFERASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 1


name: ALANINE AMINOTRANSFERASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 2


name: ALANINE AMINOTRANSFERASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 1


name: BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 12


name: Mildly flattened proximal femoral epiphyses


name: Widened metaphyses (metacarpal and phalanges)


name: Lysyl pyridinoline/hydroxylysyl pyridinoline (LP/HP) ratio approximately 1


name: Mesomelic limb shortening (lower limb greater than upper limb)


name: Skin appendage tumors may show malignant transformation


name: Parotid gland adenoma and adenocarcinoma


name: Cylindromas, multiple (usually occur on the scalp, but may also occur on the face, trunk, and extremities)


name: Trichoepitheliomas, multiple (usually occur in the nasolabial folds, nose, or face)


name: BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1


name: BREAST CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1


name: OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1


name: Severe cognitive deficits (develop later)


name: Peripheral motor and sensory neuropathy, distal


name: Nerve biopsy shows loss of myelinated fibers


name: Atrophy of the thenar and hypothenar muscles


name: Skeletal muscle shows dystrophic changes


name: Skeletal muscle shows decreased sarcoglycan proteins


name: Accumulation of PAS-positive diastase-resistant neuronal inclusion bodies in the cerebral cortex (Collins bodies)


name: Neuronal inclusion bodies stain for neuroserpin


name: MUSICAL APTITUDE QUANTITATIVE TRAIT LOCUS


name: THYROID-STIMULATING HORMONE LEVEL QUANTITATIVE TRAIT LOCUS 1


name: Severe narrowing of cartilaginous auditory canal (in homozygotes)


name: Near-stenosis of bony portion of auditory canal


name: Hearing loss, prelingual, severe to profound (affecting all frequencies)


name: Sublamina densa level of tissue separation beneath basal membrane


name: Decreased number of anchoring fibrils at dermal-epidermal junction


name: MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO


name: NEPHROPATHY, DIABETIC, SUSCEPTIBILITY TO


name: END-STAGE RENAL DISEASE, DIABETIC, SUSCEPTIBILITY TO


name: PROLIFERATIVE RETINOPATHY, DIABETIC, SUSCEPTIBILITY TO


name: NONPROLIFERATIVE RETINOPATHY, DIABETIC, SUSCEPTIBILITY TO


name: Abnormal platelets with giant morphology


name: Megakaryocytes show ultrastructural defects with abnormal membranes


name: BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 8


name: Craniosynostosis (coronal, lambdoid, sagittal)


name: Hyperkeratotic plaques (face, elbow, knees)


name: Nonspecific portal inflammation shown on biopsy


name: Abnormal bile duct proliferation shown on biopsy


name: End-stage liver disease before adulthood


name: Skin-Hair-Eye Pigmentation, Variation In, 11


name: Skin-Hair-Eye Pigmentation, Variation In, 10


name: MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 7


name: Intermittent increase of urinary ethylmalonic acid


name: Serum lactate may be increased during encephalopathic exacerbations


name: Beta-cell dysfunction of varying degrees


name: BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 9


name: Intracanalicular cholestasis shown on biopsy


name: Giant cell transformation shown on biopsy


name: Normal-to-decreased plasma glycine (fasting)


name: SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 3


name: Contractures of the proximal interphalangeal (PIP) joints


name: Trichoepitheliomas may rarely show malignant transformation to basal cell carcinoma


name: Trichoepitheliomas, multiple (usually occur in thenasolabial folds, the nose, and upper lip)


name: Tumors show hair follicle differentiation


name: Constipation due to smooth muscle involvement


name: MULTIPLE SCLEROSIS, DISEASE PROGRESSION, MODIFIER OF


name: Hearing loss, sensorineural, moderate, postlingual


name: COLORECTAL CANCER, SUSCEPTIBILITY TO, ON CHROMOSOME 15


name: Increased alpha-fetoprotein in the mother during early pregnancy while carrying an affected fetus


name: Congenital absence of skin in some areas (aplasia cutis)


name: DEJERINE-SOTTAS SYNDROME, AUTOSOMAL RECESSIVE


name: Hearing loss, sensorineural, progressive (high frequencies first affected, all frequencies later affected)


name: Motor seizures, nocturnal, usually occur in clusters (up to 8 per night) during dozing or on awakening


name: Cleavage occurs within the lower part of basal keratinocytes


name: Defective production of NFKB1-dependent cytokines by white blood cells


name: Hypertrophy, asymmetric septal (variable)


name: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 11


name: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 10


name: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 9


name: FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 1


name: Septal bulge of left ventricular outflow tract


name: Extinguished electroretinograms in second or third decade


name: Dysplasia of nasal bones with midface protrusion


name: MUSCLE STRENGTH QUANTITATIVE TRAIT LOCUS 1


name: Scalp biopsy shows absence of mature hair follicles


name: URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 2


name: Imaging shows signal abnormalities in basal ganglia


name: Peripheral neuropathy, axonal and demyelinating


name: Skeletal muscle tissue shows depletion of mitochondrial DNA (mtDNA)


name: RECOMBINATION RATE QUANTITATIVE TRAIT LOCUS 1


name: Urinary retention due to mass effect of meningocele


name: Constipation due to mass effect of meningocele


name: AR, ALA645ASP, SHORT POLYGLYCINE REPEAT, LONG POLYGLUTAMINE REPEAT


name: Atrophy and weakness of limb musculature


name: Atrophy and weakness of the tongue, jaw, and throat muscles


name: Decreased or increased serum testosterone


name: Vacuoles appear to be exocytosing material at the cell surface


name: Arrest of psychomotor development after seizure onset


name: MRI shows T2-weighted signals in the basal ganglia


name: Corneal opacities on slit-lamp examination


name: Pregnant mothers of affected children have decreased plasma and urinary estrogen


name: Decreased or absent steroid sulfatase activity


name: Lesions occur mainly on extremities, scalp, neck, and trunk


name: Sparing of flexure areas, palms, and soles


name: Short stature, final adult height 150-160cm


name: Contractures (elbows, wrists, knees, ankles)


name: Decreased vibration sense in the lower limbs


name: Lymphedema of the lower limbs (swelling is confined to below the knees)


name: Symblepharon (adhesion of the eyelid to the eyeball)


name: Streak ovaries with no discernable oocytes


name: Reduced CD3+, CD4+, and CD8+ T-lymphocytes


name: Normal numbers of CD56+ natural killer cells


name: Interalveolar fibrosis, rapidly progressive


name: Mucosal lymphoid tissue markedly reduced


name: C-REACTIVE PROTEIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1


name: Skin lesions follow the lines of Blaschko


name: Basocellular neoplasms develop after second decade


name: Follicular atrophoderma affecting the dorsa of the hands and feet, the face, and extensor surfaces of the elbows and knees


name: Facial milia tend to disappear in adulthood


name: Macrocytic anemia in manifesting females


name: Pathologic perinuclear mitochondrial iron deposits in erythrocyte precursors


name: Decreased vibratory sense after sixth decade


name: Deafness, bilateral with postpubertal onset and rapid progression to profound deafness within 5 to 6 years


name: Pigmentary changes consistent with retinitis pigmentosa


name: Skeletal muscle biopsy shows reducing bodies


name: Inclusions stain positively with nitroblue tetrazolium (NBT)


name: Central nervous system involvement in approximately 50% of patients


name: Renal failure may occur with myoglobinuria


name: Myopathy in approximately 45% of patients


name: Decreased activity of phosphoglycerate kinase 1


name: Hemolytic anemia in approximately 60% of patients


name: Non-purpuric punctate and linear erythematous rash


name: Lesions occur on the trunk, back, arms, legs, abdomen, buttocks


name: Extensive cutaneous involvement rarely occurs


name: Palms, soles, and oral mucosa are not involved


name: Nests of dilated and thick-walled capillaries in the dermal papillae


name: Slit-like protrusion of capillary lumen into the endothelial lining


name: Recurrent mycobacterial disease (BCG and M. tuberculosis)


name: Seizures provoked by tactile stimulation or extreme emotion


name: Mental retardation, borderline-mild in carrier females


name: Impaired attentional and executive function


name: EEG abnormalities in 20-50% Impaired language development


name: ARX, 24-BP DUP, NT428, ALANINE TRACT EXPANSION


name: Increased urinary creatine-to-creatinine ratio


name: BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 11


name: Severe psychomotor retardation from birth


name: Loss of any acquired abilities in early childhood


name: Spasticity, progressive, develops in childhood


name: Female carriers show markedly skewed X inactivation


name: Ptosis, bilateral symmetric Minimal levator function, bilaterally


name: Delayed development, variable severity, from birth in some patients


name: Developmental regression in about 50% of patients


name: Carrier males show controlling and inflexible traits


name: Normal female secondary sexual characteristics


name: Dysgenesis of Mullerian duct derivatives


name: Congenital absence or severe hypoplasia of the upper two-thirds of vagina


name: Congenital absence or severe hypoplasia of uterus


name: Mental retardation, severe (if untreated)


name: Growth retardation, severe (if untreated)


name: Low to normal TSH (values may vary depending on the measurement methods used)


name: Thrombocytopenia (onset birth-neonate, may be precipitated by cow's milk allergy)


name: Short, wide metacarpals (wider distally than proximally)


name: Relative increase in anterior vertebral body height


name: Biconcave vertebral bodies (later childhood)


name: Decreased proprioception in the lower limbs


name: Brain white matter hyperintensities on MRI


name: Low plasma tryptophan (inflammatory type B)


name: Superficial generalized lifelong skin peeling (sparing palms and soles)


name: Generalized erythema (inflammatory type B)


name: Cleavage at junction of stratum corneum and stratum granulosum


name: Kidney biopsy shows absence of differentiated proximal tubules


name: Hypoplasia of the membranous bones of the skull


name: Pulmonary hypoplasia secondary to oligohydramnios


name: Neonatal respiratory failure due to pulmonary hypoplasia


name: Cone-shaped epiphyses (proximal and middle phalanges)


name: Episodic inflammatory swelling of nail bed


name: Joint contractures, congenital (knee, ankle, hip, elbow)


name: Cognitive defects (variable from mild to severe)


name: Increased urinary 3-methylglutaconic acid


name: Longitudinal depressions on microscopic examination


name: Central translucency of distal phalanges of thumbs


name: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 8


name: Macroscopic specimen observation (finding)


name: Prodigy Voice Blood Glucose Monitoring System


name: {28 (everolimus 10 MG Oral Tablet) } Pack


name: {28 (everolimus 5 MG Oral Tablet) } Pack


name: CATHERIZATION SET,INTERMITTENT 10FR C#281910


name: CATHERIZATION SET,INTERMITTENT 10FR C#282410


name: CATHERIZATION SET,INTERMITTENT 12FR C#281920


name: CATHERIZATION SET,INTERMITTENT 12FR C#282420


name: CATHERIZATION SET,INTERMITTENT 14FR C#281940


name: CATHERIZATION SET,INTERMITTENT 14FR C#282440


name: DRESSING,HYDROFERA BLUE 2IN X 2IN HB2214


name: DRESSING,HYDROFERA BLUE 4IN X 4IN HB4414


name: DRESSING,HYDROFERA BLUE 6IN X 6IN HB6614


name: DRESSING,TEGADERM AG MESH 16IN X 16IN #90506


name: DRESSING,TEGADERM AG MESH 2IN X 2IN #90500


name: DRESSING,TEGADERM AG MESH 4IN X 5IN #90501


name: DRESSING,TEGADERM AG MESH 8IN X 8IN #90503


name: syringe,needle,safety 1 mL,self-contained disposal unit 25 gauge X 5/8" MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe,needle,safety 1 mL,self-contained disposal unit 27 gauge X 1/2" MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe 3 mL with safety needle,self-contained disposal unit 20 gauge X 1 1/2" MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe 3 mL with safety needle,self-contained disposal unit 20 gauge X 1" MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe 3 mL with safety needle,self-contained disposal unit 21 gauge X 1 1/2" MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe 3 mL with safety needle,self-contained disposal unit 21 gauge X 1" MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe 3 mL with safety needle,self-contained disposal unit 22 gauge X 1" MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe 3 mL with safety needle,self-contained disposal unit 23 gauge X 1 1/2" MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe 3 mL with safety needle,self-contained disposal unit 25 gauge X 1" MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe, safety needle 5 mL and self-contained disposal unit 20 gauge X 1 1/2" MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe, safety needle 5 mL and self-contained disposal unit 21 gauge X 1" MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe, safety needle 5 mL and self-contained disposal unit 22 gauge X 1 1/2" MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe, safety 10 mL, self-contained disposal unit MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe, safety 3 mL, self-contained disposal unit MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe,safety needle 10 mL and self-contained disposal unit 20 gauge X 1 1/2" MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe,safety needle 10 mL and self-contained disposal unit 20 gauge X 1" MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe,safety needle 10 mL and self-contained disposal unit 21 gauge X 1 1/2" MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe,safety needle 10 mL and self-contained disposal unit 21 gauge X 1" MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe,safety needle 10 mL and self-contained disposal unit 22 gauge X 1" MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe with needle 1 mL,insulin,safety w-self-con.disp.unit 28 gauge X 1/2" MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe with needle 1 mL,insulin,safety w-self-con.disp.unit 29 gauge X 1/2" MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe w-needle 0.3 mL,insulin,safety w-self-cont.dis.unit 30 gauge X 5/16" MISCELL SYRINGE, EMPTY DISPOSABLE


name: insulin syringe-needle,safety,disposal unit,0.5 mL 29 gauge X 1/2" MISCELL SYRINGE, EMPTY DISPOSABLE


name: insulin syringe-needle,safety,disposal unit,0.5 mL 30 gauge X 5/16" MISCELL SYRINGE, EMPTY DISPOSABLE


name: TRACH STOMA PROTECTOR,FOAM 2.375IN X 2.75IN LUMINAUD #63006


name: adhesive bandage 1 3/4" X 4" TOPICAL BANDAGE


name: syringe 3 mL with safety needle,self-contained disposal unit 22 gauge X 1 1/2" MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe 3 mL with safety needle,self-contained disposal unit 23 gauge X 1" MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe 3 mL with safety needle,self-contained disposal unit 25 gauge X 5/8" MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe, safety needle 5 mL and self-contained disposal unit 21 gauge X 1 1/2" MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe, safety needle 5 mL and self-contained disposal unit 22 gauge X 1" MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe, safety 5 mL, self-contained disposal unit MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe,safety needle 10 mL and self-contained disposal unit 22 gauge X 1 1/2" MISCELL SYRINGE, EMPTY DISPOSABLE


name: nasal exhalation resistance device NASAL EACH


name: pen needle, diabetic, safety 29 gauge X 1/2" MISCELL NEEDLE, DISPOSABLE


name: EXTERNAL CONTINENCE DEVICE BIODERM ECD #21036


name: inhaler, assist devices, accessories MISCELL EACH


name: nut.therapy, phenylketonuria (PKU), no.38


name: syringe,needle 1 mL,insulin,safety, disposal unit


name: syringe,needle 0.3 mL,insulin, safety, disp unit


name: syringe, needle, insulin, safety 0.5 mL,disp unit


name: syringe,needle,insulin, safety, self-cnt disp unit


name: syringe, safety needle 5 mL and self-contained disposal unit 20 gauge X 1" MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe 3 mL, safety needle, self-cont dispos unit


name: syringe, safety needle 5 mL, self-cont dispos unit


name: syringe, safety needle 10 mL,self-cont dispos.unit


name: syringe, needle, safety, self-cont disposal unit


name: syringe, safety 10 mL,self-contained disposal unit


name: syringe, safety 3 mL, self-cont disposal unit


name: syringe, safety 5 mL, self-cont disposal unit


name: syringe, safety, self-cont disposal unit


name: Doxycycline;Octinoxate/Zinc Oxide;Salicylic Acid 100 MG; 5.5%-8%; 2% Multiple Routes Kit


name: {21 (dexamethasone 1.5 MG Oral Tablet) } Pack


name: DRESSING,TEGADERM AG MESH 4IN X 8IN #90502


name: syringe,needle,safety 1 mL,self-cont disposal unit


name: spirometers and accessories MISCELL EACH


name: salicylic acid/benzoyl peroxide/vitamin E mixed 1 %-4 %-5 % TOPICAL COMBINATION PACKAGE (EA)


name: salicylic acid/benzoyl peroxide/vitamin E mixed 2 %-8 %-5 % TOPICAL COMBINATION PACKAGE (EA)


name: Solution, Multi Ingredient Otic Solution


name: {21 (dexamethasone 1.5 MG Oral Tablet) } Pack [DexPak TaperPak 6 Day]


name: {56 (ribavirin 400 MG Oral Tablet [RibaTab]) } Pack [Ribatab Compliance Pack]


name: Tetrofosmin 1.38 mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Myoview]


name: DRESSING,TENDERWET ACTIVE CAVITY 3IN X 3IN


name: DRESSING,TENDERWET ACTIVE CAVITY 3IN X 8IN


name: LOOP,CONSTRICTION ADJUSTABLE DEVICE ACTIS


name: CATHETER,EXTERNAL GOLDEN DRAIN SM #A1000S


name: BAG,AEROSOL DRAINAGE WITH Y CONNECTOR U#355974YE


name: DRESSING,TENDERWET ACTIVE CAVITY 4IN X 5IN


name: amino acids/protein hydrolysate 15 gram-100 kcal/30 mL ORAL LIQUID (ML)


name: {2 (iloperidone 1 MG Oral Tablet) / 2 (iloperidone 2 MG Oral Tablet) / 2 (iloperidone 4 MG Oral Tablet) / 2 (iloperidone 6 MG Oral Tablet) } Pack


name: {2 (iloperidone 1 MG Oral Tablet [Fanapt]) / 2 (iloperidone 2 MG Oral Tablet [Fanapt]) / 2 (iloperidone 4 MG Oral Tablet [Fanapt]) / 2 (iloperidone 6 MG Oral Tablet [Fanapt]) } Pack [Fanapt Titration Pack]


name: needles, safety 30 gauge X 1/2" MISCELL NEEDLE, DISPOSABLE


name: Fora D10 Blood Glucose Monitor Plus Blood Pressure System


name: Medical Food Oral Tablet, Disintegrating


name: compound vehicle suspension no.7 ORAL SUSPENSION, ORAL (FINAL DOSE FORM)


name: compounding vehicle suspension sugar-free no.6 ORAL SUSPENSION, RECONSTITUTED, ORAL (GRAM)


name: compounding vehicle suspension sugar-free no.6


name: nutritional therapy, metabolic dis., mv, min no.3


name: nutritional therapy, metabolic dis., mv, min no.4


name: Cepacol Maximum Numbing Sore Throat Plus Cough Relief


name: Tylenol Extra Strength PM Rapid Release Gelcaps


name: calcium chloride 95 % MISCELL POWDER (GRAM)


name: conception assistance supplies combination no.1 MISCELL KIT


name: conception assistance supplies combination no.1


name: creatine monohydrate 1.5 gram/15 mL ORAL LIQUID (ML)


name: Medical and Surgical @ Respiratory System @ Supplement


name: Medical and Surgical @ Respiratory System @ Supplement @ Trachea


name: Medical and Surgical @ Respiratory System @ Supplement @ Trachea @ Open


name: Medical and Surgical @ Respiratory System @ Supplement @ Trachea @ Open @ Autologous Tissue Substitute


name: Supplement Trachea with Autologous Tissue Substitute, Open Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Trachea @ Open @ Synthetic Substitute


name: Supplement Trachea with Synthetic Substitute, Open Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Trachea @ Open @ Nonautologous Tissue Substitute


name: Supplement Trachea with Nonautologous Tissue Substitute, Open Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Trachea @ Percutaneous Endoscopic


name: Medical and Surgical @ Respiratory System @ Supplement @ Trachea @ Percutaneous Endoscopic @ Autologous Tissue Substitute


name: Supplement Trachea with Autologous Tissue Substitute, Percutaneous Endoscopic Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Trachea @ Percutaneous Endoscopic @ Synthetic Substitute


name: Supplement Trachea with Synthetic Substitute, Percutaneous Endoscopic Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Trachea @ Percutaneous Endoscopic @ Nonautologous Tissue Substitute


name: Supplement Trachea with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Carina


name: Medical and Surgical @ Respiratory System @ Supplement @ Carina @ Open


name: Medical and Surgical @ Respiratory System @ Supplement @ Carina @ Open @ Autologous Tissue Substitute


name: Supplement Carina with Autologous Tissue Substitute, Open Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Carina @ Open @ Synthetic Substitute


name: Supplement Carina with Synthetic Substitute, Open Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Carina @ Open @ Nonautologous Tissue Substitute


name: Supplement Carina with Nonautologous Tissue Substitute, Open Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Carina @ Percutaneous Endoscopic


name: Medical and Surgical @ Respiratory System @ Supplement @ Carina @ Percutaneous Endoscopic @ Autologous Tissue Substitute


name: Supplement Carina with Autologous Tissue Substitute, Percutaneous Endoscopic Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Carina @ Percutaneous Endoscopic @ Synthetic Substitute


name: Supplement Carina with Synthetic Substitute, Percutaneous Endoscopic Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Carina @ Percutaneous Endoscopic @ Nonautologous Tissue Substitute


name: Supplement Carina with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Main Bronchus, Right


name: Medical and Surgical @ Respiratory System @ Supplement @ Main Bronchus, Right @ Open


name: Medical and Surgical @ Respiratory System @ Supplement @ Main Bronchus, Right @ Open @ Autologous Tissue Substitute


name: Supplement Right Main Bronchus with Autologous Tissue Substitute, Open Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Main Bronchus, Right @ Open @ Synthetic Substitute


name: Supplement Right Main Bronchus with Synthetic Substitute, Open Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Main Bronchus, Right @ Open @ Nonautologous Tissue Substitute


name: Supplement Right Main Bronchus with Nonautologous Tissue Substitute, Open Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Main Bronchus, Right @ Percutaneous Endoscopic


name: Medical and Surgical @ Respiratory System @ Supplement @ Main Bronchus, Right @ Percutaneous Endoscopic @ Autologous Tissue Substitute


name: Supplement Right Main Bronchus with Autologous Tissue Substitute, Percutaneous Endoscopic Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Main Bronchus, Right @ Percutaneous Endoscopic @ Synthetic Substitute


name: Supplement Right Main Bronchus with Synthetic Substitute, Percutaneous Endoscopic Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Main Bronchus, Right @ Percutaneous Endoscopic @ Nonautologous Tissue Substitute


name: Supplement Right Main Bronchus with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Upper Lobe Bronchus, Right


name: Medical and Surgical @ Respiratory System @ Supplement @ Upper Lobe Bronchus, Right @ Open


name: Medical and Surgical @ Respiratory System @ Supplement @ Upper Lobe Bronchus, Right @ Open @ Autologous Tissue Substitute


name: Supplement Right Upper Lobe Bronchus with Autologous Tissue Substitute, Open Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Upper Lobe Bronchus, Right @ Open @ Synthetic Substitute


name: Supplement Right Upper Lobe Bronchus with Synthetic Substitute, Open Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Upper Lobe Bronchus, Right @ Open @ Nonautologous Tissue Substitute


name: Supplement Right Upper Lobe Bronchus with Nonautologous Tissue Substitute, Open Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Upper Lobe Bronchus, Right @ Percutaneous Endoscopic


name: Medical and Surgical @ Respiratory System @ Supplement @ Upper Lobe Bronchus, Right @ Percutaneous Endoscopic @ Autologous Tissue Substitute


name: Supplement Right Upper Lobe Bronchus with Autologous Tissue Substitute, Percutaneous Endoscopic Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Upper Lobe Bronchus, Right @ Percutaneous Endoscopic @ Synthetic Substitute


name: Supplement Right Upper Lobe Bronchus with Synthetic Substitute, Percutaneous Endoscopic Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Upper Lobe Bronchus, Right @ Percutaneous Endoscopic @ Nonautologous Tissue Substitute


name: Supplement Right Upper Lobe Bronchus with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Middle Lobe Bronchus, Right


name: Medical and Surgical @ Respiratory System @ Supplement @ Middle Lobe Bronchus, Right @ Open


name: Medical and Surgical @ Respiratory System @ Supplement @ Middle Lobe Bronchus, Right @ Open @ Autologous Tissue Substitute


name: Supplement Right Middle Lobe Bronchus with Autologous Tissue Substitute, Open Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Middle Lobe Bronchus, Right @ Open @ Synthetic Substitute


name: Supplement Right Middle Lobe Bronchus with Synthetic Substitute, Open Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Middle Lobe Bronchus, Right @ Open @ Nonautologous Tissue Substitute


name: Supplement Right Middle Lobe Bronchus with Nonautologous Tissue Substitute, Open Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Middle Lobe Bronchus, Right @ Percutaneous Endoscopic


name: Medical and Surgical @ Respiratory System @ Supplement @ Middle Lobe Bronchus, Right @ Percutaneous Endoscopic @ Autologous Tissue Substitute


name: Supplement Right Middle Lobe Bronchus with Autologous Tissue Substitute, Percutaneous Endoscopic Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Middle Lobe Bronchus, Right @ Percutaneous Endoscopic @ Synthetic Substitute


name: Supplement Right Middle Lobe Bronchus with Synthetic Substitute, Percutaneous Endoscopic Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Middle Lobe Bronchus, Right @ Percutaneous Endoscopic @ Nonautologous Tissue Substitute


name: Supplement Right Middle Lobe Bronchus with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Lower Lobe Bronchus, Right


name: Medical and Surgical @ Respiratory System @ Supplement @ Lower Lobe Bronchus, Right @ Open


name: Medical and Surgical @ Respiratory System @ Supplement @ Lower Lobe Bronchus, Right @ Open @ Autologous Tissue Substitute


name: Supplement Right Lower Lobe Bronchus with Autologous Tissue Substitute, Open Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Lower Lobe Bronchus, Right @ Open @ Synthetic Substitute


name: Supplement Right Lower Lobe Bronchus with Synthetic Substitute, Open Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Lower Lobe Bronchus, Right @ Open @ Nonautologous Tissue Substitute


name: Supplement Right Lower Lobe Bronchus with Nonautologous Tissue Substitute, Open Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Lower Lobe Bronchus, Right @ Percutaneous Endoscopic


name: Medical and Surgical @ Respiratory System @ Supplement @ Lower Lobe Bronchus, Right @ Percutaneous Endoscopic @ Autologous Tissue Substitute


name: Supplement Right Lower Lobe Bronchus with Autologous Tissue Substitute, Percutaneous Endoscopic Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Lower Lobe Bronchus, Right @ Percutaneous Endoscopic @ Synthetic Substitute


name: Supplement Right Lower Lobe Bronchus with Synthetic Substitute, Percutaneous Endoscopic Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Lower Lobe Bronchus, Right @ Percutaneous Endoscopic @ Nonautologous Tissue Substitute


name: Supplement Right Lower Lobe Bronchus with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Main Bronchus, Left


name: Medical and Surgical @ Respiratory System @ Supplement @ Main Bronchus, Left @ Open


name: Medical and Surgical @ Respiratory System @ Supplement @ Main Bronchus, Left @ Open @ Autologous Tissue Substitute


name: Supplement Left Main Bronchus with Autologous Tissue Substitute, Open Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Main Bronchus, Left @ Open @ Synthetic Substitute


name: Supplement Left Main Bronchus with Synthetic Substitute, Open Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Main Bronchus, Left @ Open @ Nonautologous Tissue Substitute


name: Supplement Left Main Bronchus with Nonautologous Tissue Substitute, Open Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Main Bronchus, Left @ Percutaneous Endoscopic


name: Medical and Surgical @ Respiratory System @ Supplement @ Main Bronchus, Left @ Percutaneous Endoscopic @ Autologous Tissue Substitute


name: Supplement Left Main Bronchus with Autologous Tissue Substitute, Percutaneous Endoscopic Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Main Bronchus, Left @ Percutaneous Endoscopic @ Synthetic Substitute


name: Supplement Left Main Bronchus with Synthetic Substitute, Percutaneous Endoscopic Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Main Bronchus, Left @ Percutaneous Endoscopic @ Nonautologous Tissue Substitute


name: Supplement Left Main Bronchus with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Upper Lobe Bronchus, Left


name: Medical and Surgical @ Respiratory System @ Supplement @ Upper Lobe Bronchus, Left @ Open


name: Medical and Surgical @ Respiratory System @ Supplement @ Upper Lobe Bronchus, Left @ Open @ Autologous Tissue Substitute


name: Supplement Left Upper Lobe Bronchus with Autologous Tissue Substitute, Open Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Upper Lobe Bronchus, Left @ Open @ Synthetic Substitute


name: Supplement Left Upper Lobe Bronchus with Synthetic Substitute, Open Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Upper Lobe Bronchus, Left @ Open @ Nonautologous Tissue Substitute


name: Supplement Left Upper Lobe Bronchus with Nonautologous Tissue Substitute, Open Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Upper Lobe Bronchus, Left @ Percutaneous Endoscopic


name: Medical and Surgical @ Respiratory System @ Supplement @ Upper Lobe Bronchus, Left @ Percutaneous Endoscopic @ Autologous Tissue Substitute


name: Supplement Left Upper Lobe Bronchus with Autologous Tissue Substitute, Percutaneous Endoscopic Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Upper Lobe Bronchus, Left @ Percutaneous Endoscopic @ Synthetic Substitute


name: Supplement Left Upper Lobe Bronchus with Synthetic Substitute, Percutaneous Endoscopic Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Upper Lobe Bronchus, Left @ Percutaneous Endoscopic @ Nonautologous Tissue Substitute


name: Supplement Left Upper Lobe Bronchus with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Lingula Bronchus


name: Medical and Surgical @ Respiratory System @ Supplement @ Lingula Bronchus @ Open


name: Medical and Surgical @ Respiratory System @ Supplement @ Lingula Bronchus @ Open @ Autologous Tissue Substitute


name: Supplement Lingula Bronchus with Autologous Tissue Substitute, Open Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Lingula Bronchus @ Open @ Synthetic Substitute


name: Supplement Lingula Bronchus with Synthetic Substitute, Open Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Lingula Bronchus @ Open @ Nonautologous Tissue Substitute


name: Supplement Lingula Bronchus with Nonautologous Tissue Substitute, Open Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Lingula Bronchus @ Percutaneous Endoscopic


name: Medical and Surgical @ Respiratory System @ Supplement @ Lingula Bronchus @ Percutaneous Endoscopic @ Autologous Tissue Substitute


name: Supplement Lingula Bronchus with Autologous Tissue Substitute, Percutaneous Endoscopic Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Lingula Bronchus @ Percutaneous Endoscopic @ Synthetic Substitute


name: Supplement Lingula Bronchus with Synthetic Substitute, Percutaneous Endoscopic Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Lingula Bronchus @ Percutaneous Endoscopic @ Nonautologous Tissue Substitute


name: Supplement Lingula Bronchus with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Lower Lobe Bronchus, Left


name: Medical and Surgical @ Respiratory System @ Supplement @ Lower Lobe Bronchus, Left @ Open


name: Medical and Surgical @ Respiratory System @ Supplement @ Lower Lobe Bronchus, Left @ Open @ Autologous Tissue Substitute


name: Supplement Left Lower Lobe Bronchus with Autologous Tissue Substitute, Open Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Lower Lobe Bronchus, Left @ Open @ Synthetic Substitute


name: Supplement Left Lower Lobe Bronchus with Synthetic Substitute, Open Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Lower Lobe Bronchus, Left @ Open @ Nonautologous Tissue Substitute


name: Supplement Left Lower Lobe Bronchus with Nonautologous Tissue Substitute, Open Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Lower Lobe Bronchus, Left @ Percutaneous Endoscopic


name: Medical and Surgical @ Respiratory System @ Supplement @ Lower Lobe Bronchus, Left @ Percutaneous Endoscopic @ Autologous Tissue Substitute


name: Supplement Left Lower Lobe Bronchus with Autologous Tissue Substitute, Percutaneous Endoscopic Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Lower Lobe Bronchus, Left @ Percutaneous Endoscopic @ Synthetic Substitute


name: Supplement Left Lower Lobe Bronchus with Synthetic Substitute, Percutaneous Endoscopic Approach


name: Medical and Surgical @ Respiratory System @ Supplement @ Lower Lobe Bronchus, Left @ Percutaneous Endoscopic @ Nonautologous Tissue Substitute


name: Supplement Left Lower Lobe Bronchus with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach


name: Medical and Surgical @ Mouth and Throat @ Change @ Mouth and Throat


name: Medical and Surgical @ Mouth and Throat @ Change @ Mouth and Throat @ External


name: Medical and Surgical @ Mouth and Throat @ Change @ Mouth and Throat @ External @ Drainage Device


name: Change Drainage Device in Mouth and Throat, External Approach


name: Medical and Surgical @ Mouth and Throat @ Change @ Mouth and Throat @ External @ Other Device


name: Change Other Device in Mouth and Throat, External Approach


name: Medical and Surgical @ Upper Joints @ Fusion @ Cervical Vertebral Joints, 2 or more


name: Medical and Surgical @ Upper Joints @ Fusion @ Cervical Vertebral Joints, 2 or more @ Open


name: Medical and Surgical @ Upper Joints @ Fusion @ Cervical Vertebral Joints, 2 or more @ Open @ Autologous Tissue Substitute


name: Fusion of 2 or more Cervical Vertebral Joints with Autologous Tissue Substitute, Anterior Approach, Anterior Column, Open Approach


name: Fusion of 2 or more Cervical Vertebral Joints with Autologous Tissue Substitute, Posterior Approach, Posterior Column, Open Approach


name: Medical and Surgical @ Upper Joints @ Fusion @ Cervical Vertebral Joints, 2 or more @ Open @ Synthetic Substitute


name: Fusion of 2 or more Cervical Vertebral Joints with Synthetic Substitute, Anterior Approach, Anterior Column, Open Approach


name: Fusion of 2 or more Cervical Vertebral Joints with Synthetic Substitute, Posterior Approach, Posterior Column, Open Approach


name: Medical and Surgical @ Upper Joints @ Fusion @ Cervical Vertebral Joints, 2 or more @ Open @ Nonautologous Tissue Substitute


name: Fusion of 2 or more Cervical Vertebral Joints with Nonautologous Tissue Substitute, Anterior Approach, Anterior Column, Open Approach


name: Fusion of 2 or more Cervical Vertebral Joints with Nonautologous Tissue Substitute, Posterior Approach, Posterior Column, Open Approach


name: Medical and Surgical @ Upper Joints @ Fusion @ Cervical Vertebral Joints, 2 or more @ Percutaneous


name: Medical and Surgical @ Upper Joints @ Fusion @ Cervical Vertebral Joints, 2 or more @ Percutaneous @ Autologous Tissue Substitute


name: Fusion of 2 or more Cervical Vertebral Joints with Autologous Tissue Substitute, Anterior Approach, Anterior Column, Percutaneous Approach


name: Fusion of 2 or more Cervical Vertebral Joints with Autologous Tissue Substitute, Posterior Approach, Posterior Column, Percutaneous Approach


name: Medical and Surgical @ Upper Joints @ Fusion @ Cervical Vertebral Joints, 2 or more @ Percutaneous @ Synthetic Substitute


name: Fusion of 2 or more Cervical Vertebral Joints with Synthetic Substitute, Anterior Approach, Anterior Column, Percutaneous Approach


name: Fusion of 2 or more Cervical Vertebral Joints with Synthetic Substitute, Posterior Approach, Posterior Column, Percutaneous Approach


name: Medical and Surgical @ Upper Joints @ Fusion @ Cervical Vertebral Joints, 2 or more @ Percutaneous @ Nonautologous Tissue Substitute


name: Fusion of 2 or more Cervical Vertebral Joints with Nonautologous Tissue Substitute, Anterior Approach, Anterior Column, Percutaneous Approach


name: Fusion of 2 or more Cervical Vertebral Joints with Nonautologous Tissue Substitute, Posterior Approach, Posterior Column, Percutaneous Approach


name: Medical and Surgical @ Upper Joints @ Fusion @ Cervical Vertebral Joints, 2 or more @ Percutaneous Endoscopic


name: Medical and Surgical @ Upper Joints @ Fusion @ Cervical Vertebral Joints, 2 or more @ Percutaneous Endoscopic @ Autologous Tissue Substitute


name: Fusion of 2 or more Cervical Vertebral Joints with Autologous Tissue Substitute, Anterior Approach, Anterior Column, Percutaneous Endoscopic Approach


name: Fusion of 2 or more Cervical Vertebral Joints with Autologous Tissue Substitute, Posterior Approach, Posterior Column, Percutaneous Endoscopic Approach


name: Medical and Surgical @ Upper Joints @ Fusion @ Cervical Vertebral Joints, 2 or more @ Percutaneous Endoscopic @ Synthetic Substitute


name: Fusion of 2 or more Cervical Vertebral Joints with Synthetic Substitute, Anterior Approach, Anterior Column, Percutaneous Endoscopic Approach


name: Fusion of 2 or more Cervical Vertebral Joints with Synthetic Substitute, Posterior Approach, Posterior Column, Percutaneous Endoscopic Approach


name: Medical and Surgical @ Upper Joints @ Fusion @ Cervical Vertebral Joints, 2 or more @ Percutaneous Endoscopic @ Nonautologous Tissue Substitute


name: Fusion of 2 or more Cervical Vertebral Joints with Nonautologous Tissue Substitute, Anterior Approach, Anterior Column, Percutaneous Endoscopic Approach


name: Fusion of 2 or more Cervical Vertebral Joints with Nonautologous Tissue Substitute, Posterior Approach, Posterior Column, Percutaneous Endoscopic Approach


name: Medical and Surgical @ Upper Joints @ Fusion @ Thoracic Vertebral Joints, 8 or more


name: Medical and Surgical @ Upper Joints @ Fusion @ Thoracic Vertebral Joints, 8 or more @ Open


name: Medical and Surgical @ Upper Joints @ Fusion @ Thoracic Vertebral Joints, 8 or more @ Open @ Autologous Tissue Substitute


name: Fusion of 8 or more Thoracic Vertebral Joints with Autologous Tissue Substitute, Anterior Approach, Anterior Column, Open Approach


name: Fusion of 8 or more Thoracic Vertebral Joints with Autologous Tissue Substitute, Posterior Approach, Posterior Column, Open Approach


name: Medical and Surgical @ Upper Joints @ Fusion @ Thoracic Vertebral Joints, 8 or more @ Open @ Synthetic Substitute


name: Fusion of 8 or more Thoracic Vertebral Joints with Synthetic Substitute, Anterior Approach, Anterior Column, Open Approach


name: Fusion of 8 or more Thoracic Vertebral Joints with Synthetic Substitute, Posterior Approach, Posterior Column, Open Approach


name: Medical and Surgical @ Upper Joints @ Fusion @ Thoracic Vertebral Joints, 8 or more @ Open @ Nonautologous Tissue Substitute


name: Fusion of 8 or more Thoracic Vertebral Joints with Nonautologous Tissue Substitute, Anterior Approach, Anterior Column, Open Approach


name: Fusion of 8 or more Thoracic Vertebral Joints with Nonautologous Tissue Substitute, Posterior Approach, Posterior Column, Open Approach


name: Medical and Surgical @ Upper Joints @ Fusion @ Thoracic Vertebral Joints, 8 or more @ Percutaneous


name: Medical and Surgical @ Upper Joints @ Fusion @ Thoracic Vertebral Joints, 8 or more @ Percutaneous @ Autologous Tissue Substitute


name: Fusion of 8 or more Thoracic Vertebral Joints with Autologous Tissue Substitute, Anterior Approach, Anterior Column, Percutaneous Approach


name: Fusion of 8 or more Thoracic Vertebral Joints with Autologous Tissue Substitute, Posterior Approach, Posterior Column, Percutaneous Approach


name: Medical and Surgical @ Upper Joints @ Fusion @ Thoracic Vertebral Joints, 8 or more @ Percutaneous @ Synthetic Substitute


name: Fusion of 8 or more Thoracic Vertebral Joints with Synthetic Substitute, Anterior Approach, Anterior Column, Percutaneous Approach


name: Fusion of 8 or more Thoracic Vertebral Joints with Synthetic Substitute, Posterior Approach, Posterior Column, Percutaneous Approach


name: Medical and Surgical @ Upper Joints @ Fusion @ Thoracic Vertebral Joints, 8 or more @ Percutaneous @ Nonautologous Tissue Substitute


name: Fusion of 8 or more Thoracic Vertebral Joints with Nonautologous Tissue Substitute, Anterior Approach, Anterior Column, Percutaneous Approach


name: Fusion of 8 or more Thoracic Vertebral Joints with Nonautologous Tissue Substitute, Posterior Approach, Posterior Column, Percutaneous Approach


name: Medical and Surgical @ Upper Joints @ Fusion @ Thoracic Vertebral Joints, 8 or more @ Percutaneous Endoscopic


name: Medical and Surgical @ Upper Joints @ Fusion @ Thoracic Vertebral Joints, 8 or more @ Percutaneous Endoscopic @ Autologous Tissue Substitute


name: Fusion of 8 or more Thoracic Vertebral Joints with Autologous Tissue Substitute, Anterior Approach, Anterior Column, Percutaneous Endoscopic Approach


name: Fusion of 8 or more Thoracic Vertebral Joints with Autologous Tissue Substitute, Posterior Approach, Posterior Column, Percutaneous Endoscopic Approach


name: Medical and Surgical @ Upper Joints @ Fusion @ Thoracic Vertebral Joints, 8 or more @ Percutaneous Endoscopic @ Synthetic Substitute


name: Fusion of 8 or more Thoracic Vertebral Joints with Synthetic Substitute, Anterior Approach, Anterior Column, Percutaneous Endoscopic Approach


name: Fusion of 8 or more Thoracic Vertebral Joints with Synthetic Substitute, Posterior Approach, Posterior Column, Percutaneous Endoscopic Approach


name: Medical and Surgical @ Upper Joints @ Fusion @ Thoracic Vertebral Joints, 8 or more @ Percutaneous Endoscopic @ Nonautologous Tissue Substitute


name: Fusion of 8 or more Thoracic Vertebral Joints with Nonautologous Tissue Substitute, Anterior Approach, Anterior Column, Percutaneous Endoscopic Approach


name: Fusion of 8 or more Thoracic Vertebral Joints with Nonautologous Tissue Substitute, Posterior Approach, Posterior Column, Percutaneous Endoscopic Approach


name: Removal of Drainage Device from Cerebral Ventricle, Open Approach


name: Removal of Monitoring Device from Cerebral Ventricle, Open Approach


name: Removal of Infusion Device from Cerebral Ventricle, Open Approach


name: Removal of Neurostimulator Lead from Cerebral Ventricle, Open Approach


name: Removal of Drainage Device from Cerebral Ventricle, Percutaneous Approach


name: Removal of Monitoring Device from Cerebral Ventricle, Percutaneous Approach


name: Removal of Infusion Device from Cerebral Ventricle, Percutaneous Approach


name: Removal of Neurostimulator Lead from Cerebral Ventricle, Percutaneous Approach


name: Removal of Drainage Device from Cerebral Ventricle, Percutaneous Endoscopic Approach


name: Removal of Monitoring Device from Cerebral Ventricle, Percutaneous Endoscopic Approach


name: Removal of Infusion Device from Cerebral Ventricle, Percutaneous Endoscopic Approach


name: Removal of Neurostimulator Lead from Cerebral Ventricle, Percutaneous Endoscopic Approach


name: Removal of Drainage Device from Spinal Canal, Open Approach


name: Removal of Monitoring Device from Spinal Canal, Open Approach


name: Removal of Infusion Device from Spinal Canal, Open Approach


name: Removal of Neurostimulator Lead from Spinal Canal, Open Approach


name: Removal of Drainage Device from Spinal Canal, Percutaneous Approach


name: Removal of Monitoring Device from Spinal Canal, Percutaneous Approach


name: Removal of Infusion Device from Spinal Canal, Percutaneous Approach


name: Removal of Neurostimulator Lead from Spinal Canal, Percutaneous Approach


name: Removal of Drainage Device from Spinal Canal, Percutaneous Endoscopic Approach